Monitoring Oedema in Heart Failure to Improve Function and Reduce Hospitalisation Risk

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.

Also called NCT07067658

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 300 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07067658
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07067658. Randomized; quadruple masking; primary purpose prevention. Start 2025-12-18 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Monitoring Oedema in Heart Failure to Improve Function and Reduce Hospitalisation Risk
Acronym
ME-HF
Condition
Heart Failure
Intervention (Device)
Installation of Heartfelt Device
Intervention (Other)
Enhanced Standard care
Intervention (Other)
Questionnaires
Intervention (Device)
Heartfelt device alerting system
Lead sponsor
Heartfelt Technologies (class: industry)
Collaborator
Manchester University NHS Foundation Trust (class: other government)
Collaborator
University of Glasgow (class: other)

Record details

Record id
cardio:ct-nct07067658
Content hash
9d47e81799278d117e2137ca22209151902237a048c226ec25d80403bc00c0b8